This is a firm fixed-price purchase order awarded by the National Heart, Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to GSL Biotech, LLC (doing business as Snapgene), a self-certified small disadvantaged business. The $16,200.00 contract is to extend Snapgene's software subscription in order to provide licenses to NHLBI researchers in support of their scientific research. Snapgene provides advanced molecular biology software tools for DNA/RNA sequence analysis, cloning, and data visualization. This contract is classified as a total small business set-aside and will run through December 14, 2025.
Generated 1/28/25, 12:10 PM